Inventor · disambiguated record
Ralph Buttyan
Also filed as: BUTTYAN RALPH
4 granted patents·3 pending applications·60 citations·filing 1995–2021
77Inventor score
Top patents by PatentIndex Score
7 records- 0166US6087098AEnhanced reverse transcriptase polymerase chain assay to detect MN in patients with renal cell carcinomaUNIV COLUMBIA·Filed 1997·Granted Jul 11, 2000·32 cites·6 claims
- 0255US2009311716A1METHODS TO TREAT OR PREVENT HORMONE-RESISTANT PROSTATE CANCER USING siRNA SPECIFIC FOR PROTOCADHERIN-PC, OR OTHER INHIBITORS OF PROTOCADHERIN-PC EXPRESSION OR ACTIVITYUNIV COLUMBIA·Filed 2009·Application pending·0 cites
- 0352US5976794AMethod for molecular staging of prostate cancerUNIV COLUMBIA·Filed 1995·Granted Nov 2, 1999·15 cites·36 claims
- 0452US5840494AMethod for molecular staging of prostate cancerUNIV COLUMBIA·Filed 1997·Granted Nov 24, 1998·11 cites·5 claims
- 0550US2023105654A1Molecular classifiers for prostate cancerONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2021·Application pending·0 cites
- 0648US2007248535A1Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activityINST NAT SANTE RECH MED·Filed 2006·Application pending·0 cites
- 0732US6451532B1Enhanced reverse transcriptase polymerase chain assay to detect MN in patients with renal cell carcinomaUNIV COLUMBIA·Filed 1999·Granted Sep 17, 2002·2 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Ralph Buttyan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →